Publications by authors named "Georg Pall"

Claim this Profile
W
Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC.
Stefan Koeck, Arno Amann, Johan Kern, Marit Zwierzina, Edith Lorenz, Georg Pall

Oncoimmunology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer.
Sandro M Wagner, Teresa Magnes, Thomas Melchardt, Dominik Kiem, Lukas Weiss, Georg Pall

Anticancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer.
Stefan Salcher, Gregor Sturm, Lena Horvath, Gerold Untergasser, Christiane Kuempers, Georg Pall

Cancer Cell· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations.
Gabriele Gamerith, Marcel Kloppenburg, Finn Mildner, Arno Amann, Sabine Merkelbach-Bruse, Georg Pall

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience with capmatinib in exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program.
Oliver Illini, Hannah Fabikan, Aurélie Swalduz, Anders Vikström, Dagmar Krenbek, Georg Pall

Ther Adv Med Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer : A retrospective Austrian multicenter study.
Sabine Geiger-Gritsch, Horst Olschewski, Florian Kocher, Robert Wurm, Gudrun Absenger, Georg Pall

Wien Klin Wochenschr· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the treatment of RET-fusion-positive lung cancer.
Georg Pall, Oliver Gautschi

Lung Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program.
Oliver Illini, Maximilian Johannes Hochmair, Hannah Fabikan, Christoph Weinlinger, Amanda Tufman, Georg Pall

Ther Adv Med Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant immunotherapy in nonsmall cell lung cancer.
Georg Pall

Curr Opin Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review: Soluble immunological biomarkers in advanced non-small-cell lung cancer (NSCLC).
Finn Mildner, Sieghart Sopper, Arno Amann, Andreas Pircher, Georg Pall

Crit Rev Oncol Hematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine.
Jan-Paul Bohn, Vera Reinstadler, Georg Pall, Günther Stockhammer, Michael Steurer

Eur J Drug Metab Pharmacokinet· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.
Alexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Georg Pall

J Immunother Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
Monika Sztankay, Johannes Maria Giesinger, August Zabernigg, Elisabeth Krempler, Georg Pall

BMC Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors.
Dennis Plenker, Maximilian Riedel, Johannes Brägelmann, Marcel A Dammert, Rakhee Chauhan, Georg Pall

Sci Transl Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.
Oliver Gautschi, Julie Milia, Thomas Filleron, Juergen Wolf, David P Carbone, Georg Pall

J Clin Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors.
Jan-Paul Bohn, Georg Pall, Guenther Stockhammer, Michael Steurer

Target Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).
Wolfgang Hilbe, Georg Pall, Florian Kocher, Andreas Pircher, August Zabernigg

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients.
Sebastian Michels, Andreas Hans Scheel, Matthias Scheffler, Anne Maria Schultheis, Oliver Gautschi, Georg Pall

J Thorac Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort.
Oliver Gautschi, Julie Milia, Bastien Cabarrou, Marie-Virginia Bluthgen, Benjamin Besse, Georg Pall

J Thorac Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The next-generation ALK inhibitors.
Georg Pall

Curr Opin Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.
Andreas Pircher, Gabriele Gamerith, Arno Amann, Susanne Reinold, Helmut Popper, Georg Pall

Lung Cancer· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract.
August Zabernigg, Johannes M Giesinger, Georg Pall, Eva-Maria Gamper, Klaus Gattringer

BMC Cancer· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases.
Reto Bale, Gerlig Widmann, Peter Schullian, Marion Haidu, Georg Pall

Eur Radiol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer.
Andreas Pircher, Ernst Ulsperger, Rene Hack, Herbert Jamnig, Georg Pall

Anticancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Small cell lung cancer].
Stefan Hoschek, Ursula Hoschek-Risslegger, Michael Fiegl, August Zabernigg, Georg Pall

Wien Klin Wochenschr· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis